Phathom Pharmaceuticals to Participate at Upcoming Investor Healthcare Conferences
Phathom Pharmaceuticals (Nasdaq: PHAT) announced its management team will participate in two virtual investor conferences in December 2020:
- Evercore ISI 3rd Annual HealthCONx Conference
Date: December 1, 2020
Live Presentation Time: 10:55 am ET - Piper Sandler 32nd Annual Virtual Healthcare Conference
Date: December 2, 2020
Pre-recorded presentation available online
Additionally, one-on-one meetings will be held during these events. For access to the presentations, visit Phathom's website.
- None.
- None.
FLORHAM PARK, N.J., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate at two upcoming virtual investor conferences in December, including:
- Evercore ISI 3rd Annual HealthCONx Conference
Date: December 1, 2020
Live Presentation Time: 10:55 am ET
- Piper Sandler 32nd Annual Virtual Healthcare Conference
Date: December 2, 2020
Pre-recorded presentation available online
Executive management will also participate in one-on-one meetings during the duration of the conferences.
To access the live webcast and archived recordings for each presentation, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. Recordings will be available for 30 days following each event.
About Phathom
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders. For more information about Phathom, visit the Company’s website at www.phathompharma.com or follow the Company on social media: LinkedIn at www.linkedin.com/company/phathompharma and Twitter @PhathomPharma.
CONTACTS
Media Contact:
Nick Benedetto
1-877-742-8466
media@phathompharma.com
Investor Contact:
Todd Branning
1-877-742-8466
ir@phathompharma.com
FAQ
What is the date of the Evercore ISI HealthCONx Conference for Phathom Pharmaceuticals?
When will the Piper Sandler Healthcare Conference take place for Phathom Pharmaceuticals?
How can I access the presentations for Phathom Pharmaceuticals' investor conferences?
What is the stock symbol for Phathom Pharmaceuticals?